Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1

Journal of Computer Assisted Tomography

Volumn 27, Issue 5, 2003, Pages 681-686

  Sheikh, Shams F ^a   Kubal, Wayne S ^a   Anderson, Adam W ^b   Mutalik, Pradeep ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Central nervous system; Children; Diffusion study; Magnetic resonance; Neurofibromatosis

Indexed keywords

PEDIATRICS; REGRESSION ANALYSIS; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; CENTRAL NERVOUS SYSTEMS; CHILD; COMPARISON GROUP; DIFFUSION STUDIES; DIFFUSION WEIGHTED IMAGING; HAMARTOMA; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1; PEDIATRIC PATIENTS;

MAGNETIC RESONANCE;

MYELIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; CEREBELLUM TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; EXTRACELLULAR SPACE; HUMAN; IMAGE ANALYSIS; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0042887321     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200309000-00004     Document Type: Article

References (24)

1. Sevick RJ, Barkovich AJ, Edwards MS, et al. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR. 1992;159:171-175.
2. Itoh T, Magnaldi S, White R, et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR. 1994;15:1513-1519.
3. DiPaolo DP, Zimmerman RA, Rorke LB, et al. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology. 1995;195:721-724.
4. Braffman BH, Bilaniuk LT, Zimmerman RA. The central nervous system manifestations of phakomatosis on MR. Radiol Clin North Am. 1988;26:885-891.
5. Castillo M, Kwock L, Green C, et al. Proton MR spectroscopy in a possible enhancing hamartoma in a patient with neurofibromatosis type 1. AJNR. 1995;16:993-996.
6. Bonawitz C, Castillo M, Chin TC, et al. Usefulness of contrast material in MR of patients with neurofibromatosis type 1. AJNR. 1998;19:541-546.
7. Menor F, Marti-Bonmati L, Arana E, et al. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol. 1998;26:121-131.
8. Terada H, Barkovich AJ, Edwards MSB, et al. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR. 1996;17:755-760.
9. Jones AP, Gunawardena WJ, Coutinho CMA. 1H MR spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. Neuroradiology. 2001;43:62-67.
10. Brown R. On the general existence of active molecules in organic and inorganic bodies. Philos Mag Ann Philos. 1828; New Series: 4.
11. van Zijl PCM, Davis D, Moonen CTW. In: Gillies RJ, ed. NMR Physiology and Biomedicine. San Diego, CA: Academic Press, 1994:185-198.
12. Holodny AI, Ollenschlager M. Diffusion imaging in brain tumors. Neuroimag Clin North Am. 2002;12(1):107-124.
13. Stadnick TW, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging ofintracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR. 2001;22:969-976.
14. Bammer R, Fazekas F. Diffusion imaging in multiple sclerosis. Neuroimag Clin North Am. 2002;12(1):71-106.
15. Mori H, Abe O, Okubo T, et al. Diffusion property in a hamartomatous lesion of neurofibromatosis type 1. J Comput Assist Tomogr. 2001;25:537-539.
16. Berdette JH, Elster AD, Ricci PE. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr. 1998;22(5):792-794.
17. Armitage P. Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific; 1980:279-301.
18. Eastwood JD, Fiorella DJ, MacFall JF, et al. Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology. 2001;219:354-358.
19. Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology. 2002;222:410-418.
20. Armitage P. Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific; 1980:156-162.
21. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR. 2001;177:449-454.
22. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys. 1965;42:288-292.
23. Stejskal EO, Tanner JE. Use of spin echo in pulsed magnetic field gradient to study anisotropic restricted diffusion and flow. J Chem Phys. 1965;43:3579-3603.
24. Le Bihan D, Lallemand D, Grenier P, et al. MR imaging of intravoxel incoherent motions. Application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.